US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 3.430
  • -0.180-4.99%
Close Jan 8 16:00 ET
  • 3.430
  • 0.0000.00%
Post 20:01 ET
2.39MMarket Cap-0.12P/E (TTM)

About Transcode Therapeutics Company

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Newton, MA.

Company Profile

SymbolRNAZ
Company NameTranscode Therapeutics
Listing DateJul 9, 2021
Issue Price4.00
Founded2016
CEOMr. Thomas A. Fitzgerald, M.B.A.
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address73b Chapel Street
CityNewton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02458
Phone1-857-837-3099

Company Executives

  • Name
  • Position
  • Salary
  • Thomas A. Fitzgerald, M.B.A.
  • Interim President, Chief Executive Officer, Director, Vice President, Chief Financial Officer and Principal Accounting Officer
  • 426.86K
  • Dr. Zdravka Medarova
  • Chief Scientific Officer
  • --
  • Dr. Philippe P. Calais, PhD
  • Executive Chairman of the Board
  • 112.61K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 75.11K
  • Dr. Erik Manting, PhD
  • Independent Director
  • 73.11K
  • Dr. Anna Moore, PhD
  • Scientific Advisor
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.